Mersana Therapeutics
MRSN
MRSN
157 hedge funds and large institutions have $437M invested in Mersana Therapeutics in 2023 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 51 increasing their positions, 44 reducing their positions, and 20 closing their positions.
Holders
157
Holders Change
+5
Holders Change %
+3.29%
% of All Funds
2.51%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
26
Increased
51
Reduced
44
Closed
20
Calls
$8.89M
Puts
$662K
Net Calls
+$8.23M
Net Calls Change
+$8.18M
Top Buyers
1 |
APM
1
Avidity Partners Management
Dallas,
Texas
|
$14.1M |
2 |
BBA
2
Baker Bros. Advisors
New York
|
$7.75M |
3 |
B
3
Braidwell
Stamford,
Connecticut
|
$13.8M |
4 |
5VM
4
5AM Venture Management
San Francisco,
California
|
$4.87M |
5 |
5
Goldman Sachs
New York
|
$12.1M |